05/09/2024
11:15 PM | Elevation Oncology (Filer)
| Form EFFECT | |
05/02/2024
7:01 AM | Elevation Oncology (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/02/2024
6:47 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:01 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:25 PM | Elevation Oncology (Filer)
| Form ARS | |
04/26/2024
3:20 PM | Elevation Oncology (Filer)
| Form DEFA14A | |
04/26/2024
3:15 PM | Elevation Oncology (Filer)
| Form DEF 14A | |
|
04/09/2024
3:26 PM | Elevation Oncology (Subject)
Frazier Life Sciences Public Fund, L.P. (Filed by)
| Form SC 13G | |
04/05/2024
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
7:14 AM | Elevation Oncology (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/06/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
6:00 AM | Elevation Oncology (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:40 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:28 PM | Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:16 PM | Cherrington Julie M (Reporting)
Elevation Oncology (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
3:21 PM | Elevation Oncology (Issuer)
Sandler Alan B. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
02/20/2024
3:48 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:42 PM | Elevation Oncology (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G | |
02/14/2024
3:45 PM | Elevation Oncology (Subject)
K2 HealthVentures Equity Trust LLC (Filed by)
| Form SC 13G/A | |
01/31/2024
3:32 PM | Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G/A | |
01/23/2024
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/22/2024
3:57 PM | Elevation Oncology (Subject)
Logos Global Management LP (Filed by)
| Form SC 13G | |
01/22/2024
3:35 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
3:24 PM | Elevation Oncology (Issuer)
Mootz Darcy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/22/2024
8:02 AM | Elevation Oncology (Subject)
Farallon Capital Partners, L.P. (Filed by)
| Form SC 13G | |
01/22/2024
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/09/2024
3:24 PM | Elevation Oncology (Subject)
Qiming U.S. Healthcare GP II, LLC (Filed by)
| Form SC 13G/A | |
01/09/2024
8:07 AM | Elevation Oncology (Subject)
Empery Asset Management, LP (Filed by)
| Form SC 13G | |
01/05/2024
6:40 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/02/2023
6:00 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/22/2023
3:30 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:15 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:42 PM | CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/03/2023
6:01 AM | Elevation Oncology (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/03/2023
6:15 AM | Elevation Oncology (Filer)
| Form 424B5 | |
08/03/2023
6:45 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/14/2023
3:29 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/14/2023
3:26 PM | Elevation Oncology (Issuer)
Furlong Tammy (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/14/2023
3:17 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Everybody laughed when he recommended Netflix (Ad) "This Could be Worth Even More than A.I."
Whitney Tilson's nailed many of the most famous stocks of the last 25 years – including Netflix, Amazon, and Apple. Now he's pounding the table on a new technology rolling out across America, which early estimates say could create more wealth than A.I., the personal computer, and the smartphone combined. Click here to see how it could become the No. 1 investment of the next decade. |
07/13/2023
7:15 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2023
3:12 PM | CLACKSON TIMOTHY P (Reporting)
Elevation Oncology (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:13 PM | Elevation Oncology (Issuer)
Hu Lori (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:15 PM | Elevation Oncology (Issuer)
Walsh Colin (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:06 PM | Elevation Oncology (Issuer)
Ferra Joseph J Jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:15 PM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
3:30 PM | Elevation Oncology (Subject)
venBio Global Strategic Fund III, L.P. (Filed by)
| Form SC 13D/A | |
06/08/2023
3:30 PM | Elevation Oncology (Subject)
INTEGRATED CORE STRATEGIES LLC (0001319244) (Filed by)
| Form SC 13G | |
06/05/2023
6:00 AM | Elevation Oncology (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2023
4:15 PM | Elevation Oncology (Subject)
Point72 Asset Management, L.P. (Filed by)
| Form SC 13G | |
